Tirbanibulin
CAS 897016-82-9 4 FDA-DMF suppliersSmall Molecule
Overview
Tirbanibulin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL571546).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Tirbanibulin expires 6 Sept 2038 and exclusivity 6 Jun 2027. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- N-benzyl-2-[5-[4-(2-morpholin-4-ylethoxy)phenyl]-2-pyridinyl]acetamide
- Canonical SMILES
- C1COCCN1CCOC2=CC=C(C=C2)C3=CN=C(C=C3)CC(=O)NCC4=CC=CC=C4
- InChIKey
- HUNGUWOZPQBXGX-UHFFFAOYSA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.